Sign inJoin waitlistJoin the waitlist

Robert Galvin

Assistant Professor, Division of Pediatric Hematology/Oncology · University of Minnesota

Credentials: · · · ·

History

University of Minnesota
Present

Pediatric Hematology-Oncology
University of Minnesota
2019–2020
Pediatrics
University of Minnesota
2016–2019
Virginia Commonwealth University School of Medicine
2012–2016

Research

Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib
Review · Current Oncology Reports · 2021 · First of 6 authors · 22 citations
Characterizing Immune-Mediated Cytopenias After Allogeneic Hematopoietic Cell Transplantation for Pediatric Nonmalignant Disorders
Transplantation and Cellular Therapy · 2021 · First of 6 authors · 8 citations
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon
Review · npj Precision Oncology · 2025 · 3 citations

Lucie Turcotte
3 papers
Adam Green
2 papers
Can Ozutemiz
2 papers · 1 as a fellow
Carolina Garcia
2 papers
CM
Christopher Moertel
2 papers
CE
Craig Erker
2 papers
Greg Armstrong
2 papers
Joseph Neglia
2 papers
Miriam Conces
2 papers
Sheila McThenia
2 papers
Sohil Patel
2 papers
Ahmed Elbermawy
1 paper · 1 as a resident

Clinical trials

A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
Principal investigator · Recruiting · Early phase 1
University of Minnesota
2025–2027
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Site PI · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
2022–2027